Erling Haaland was asked about Norway’s Group I decider against Kylian Mbappe’s France.
“I don't care much. They'll probably beat us and win the title.” 😂
🗣️ “It was surely Messi's last World Cup match. He'll be 35 by the next World Cup in Qatar.”
That was said 8 years ago. 😳
Since then, he's won the World Cup, and now, at 39, has already scored five goals in just two matches at another World Cup. 🤯
I'm a cardiologist. I've held dying hearts in my hands in the cath lab at 3 AM. And I need to tell you something that changes everything about how we prevent heart attacks.
For decades, the entire field was built on one target: lower LDL cholesterol. Statins save lives — that's settled science. But too many of my patients did everything right — took their statins, hit their numbers, lived clean — and still ended up on my table with a ruptured artery.
We were treating the smoke while the fire kept burning.
The fire is inflammation. And the evidence is now overwhelming.
The CANTOS trial proved it first — lowering inflammation independent of cholesterol reduced cardiac events. But the newer data is what keeps me up at night.
AI-enhanced CT angiography can now detect inflamed arteries by measuring changes in the fat surrounding your coronary vessels — the perivascular fat attenuation index. Higher inflammation in the fat around even one artery independently predicts cardiac death. When multiple arteries show inflammation, the risk multiplies dramatically — even in patients whose cholesterol looks perfect.
This isn't theoretical. This is measurable. Right now. On a scan you can get this month.
Low-dose colchicine — a drug that's been around for centuries for gout — is now FDA-approved specifically for reducing cardiovascular events. It works by quieting the inflammatory cascade that destabilizes the plaque sitting in your arteries. A pill that costs pennies is saving lives the statins couldn't reach.
And the next wave is already in Phase 3 trials. Ziltivekimab — an IL-6 inhibitor — targets the central inflammatory pathway driving atherosclerosis. Phase 2 data showed a 90% reduction in hsCRP. The ZEUS cardiovascular outcomes trial is enrolling now, with results expected late 2026 into 2027. If positive, anti-inflammatory therapy will become standard in managing heart disease alongside lipid-lowering. The era of inflammation-targeted cardiology is arriving.
But it goes deeper than drugs. AI is now predicting heart failure and cardiac events 5+ years before symptoms — integrating CT imaging, electronic health records, and genetic data with accuracy that jumps far beyond traditional risk calculators.
And polygenic risk scores — a simple genetic test that flags inherited cardiovascular risk — are now formally recognized as a risk-enhancing factor in the 2026 ACC/AHA guidelines. A single blood draw can reveal risk that's been silently building since birth. Decades before the first chest pain.
Here's what this means for you right now — today:
Ask your doctor for a high-sensitivity CRP test. It's cheap, routine, and measures the systemic inflammation that standard cholesterol panels completely miss. You can have perfect LDL and inflamed arteries that are quietly preparing to rupture.
If your hsCRP is elevated, discuss low-dose colchicine with your physician. It's FDA-approved for exactly this.
Push for a coronary CT angiography with AI plaque and inflammation analysis if you have risk factors. This isn't the stress test your parents got. This is 3D visualization of your actual arteries — with AI quantifying not just how much plaque you have, but what kind it is and whether the surrounding tissue is inflamed.
Consider polygenic risk score testing — especially with a family history of early heart disease. It's now guideline-supported.
And the foundation that never changes: move daily, eat real food, sleep 7-9 hours, manage stress, and know your numbers — ApoB, Lp(a), hsCRP, fasting insulin.
I left Iran as a child with nothing. I rebuilt everything in a country that gave me the freedom to become a physician. I've spent twenty years watching patients get second chances.
The ones who haunt me aren't the ones who died on my table. They're the ones who survived but never acted on what the science was telling them — years before the event that didn't have to happen.
You can have perfect cholesterol and still have a heart attack. Inflammation plus genetics can drive plaque rupture in arteries that look "fine" on a standard panel.
The myth that normal cholesterol means you're safe has cost more lives than I can count.
We now have the tools to detect the fire — not just the smoke. AI to see it. Genetics to predict it. Drugs to quiet it. And the ancient basics — movement, real food, sleep, purpose — to prevent it from starting.
Prevention is the new cure. And the science to make it real is no longer coming.
It's here.
Reading glasses might be done.
The FDA just approved a once-daily eye drop called VIZZ that sharpens near vision in about 30 minutes and keeps it sharp for up to 10 hours.
One drop. Each eye. Per day.
That's it.
The active ingredient is aceclidine, a compound first used back in 1975 to treat glaucoma. Scientists figured out it could be repurposed to gently shrink the pupil, creating a "pinhole effect" that pulls close-up text back into focus, the same trick your eye does when you squint.
Unlike Vuity, the 2021 drop that came before it, VIZZ doesn't mess with your focusing muscles. So no blurry distance vision. No brow ache. No weird zoom effect.
It was tested across more than 30,000 treatment days with no major complications.
Cost is roughly $2 a day.
This matters because presbyopia, the age-related slide that hits most people between 40 and 45, already affects more than 120 million Americans. By 2030, the World Health Organization expects around 2 billion people worldwide to have it.
LENZ Therapeutics, the maker, started rolling out samples in October.
The squint era is ending.
Source: Ynetnews, FOX 26 Houston, Yahoo News
Hydroxychloroquine allows viruses to attack cancer cells while leaving healthy cells alone.
Seems like information the public deserves to know.
Why do you think they tried to obscure this data in the study? Maybe because it would be bad for the cancer industry’s business.
🚨 IT’S OFFICIAL: Epidemiologist Nicolas Hulscher Says IVERMECTIN and FENBENDAZOL Are Showing Documented Stage IV Cancer Remissions — Big Pharma Cannot Ignore This Anymore | VIDEO
🚨 A global medical firestorm is erupting after epidemiologist Nicolas Hulscher highlighted scientific reports documenting stage IV cancer remissions involving #ivermectin and #fenbendazole , reigniting worldwide debate over Big Pharma, alternative therapies, and the future of cancer treatment.
🚨 THE STAGE IV REMISSION CASES NOW SHOCKING THE MEDICAL WORLD
FOLLOW ME, THE NEXT DROP WILL BE SHOCKING.
Mel Gibson isn't lying... our new study found 84% of cancer patients taking ivermectin + mebendazole declared either COMPLETE REMISSION, TUMOR SHRINKAGE, or HALTED TUMOR GROWTH after 6 months.
There are places we pass through in life… and there are places that become part of who we are.
Manchester will forever be my home.
To the city, the club, and every supporter, my sincerest thank you. These past four years have been unforgettable, filled with moments my family and I will carry with us for the rest of our lives. There simply aren’t enough words to describe the happiness and warmth we’ve felt here.
Thank you for every cheer, every memory, and for making us feel at home from the very first day.
Forever a Red Devil ❤️
The secret to living to 100?
HIGH CHOLESTEROL
A massive Swedish study tracking over 800,000 people for 35 years just revealed: Every single centenarian had HIGH total cholesterol. The higher your LDL, the longer you live.
FAUCI CAUGHT ON TAPE: "When you make it difficult for people in their lives, they lose their ideological BS and they get VACCINATED."
"You want to come to this college, buddy? You're going to get VACCINATED."
ONE WEEK LEFT TO PROSECUTE HIM.
The decision should be EASY.
Today, we took long-overdue action to restore science, accountability, and the rule of law.
In September 2023, the Biden FDA pushed a number of peptides into Category 2 — “Bulk Drug Substances that Raise Significant Safety Risks” — driving a dangerous black market that puts Americans at risk.
Now, after nominators withdrew 12 peptides, the FDA will remove them from Category 2 and will bring them to PCAC at its next two meetings, beginning in July—where independent experts will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence.
• BPC-157
• Thymosin beta-4 fragment (LKKTETQ)
• Epitalon
• GHK-Cu (injectable)
• MOTS-c
• DSIP (Emideltide)
• Dihexa Acetate
• Ibutamoren Mesylate
• Melanotan II
• KPV
• Semax (heptapeptide)
• Cathelicidin LL-37
This action begins to restore regulated access and will immediately begin shifting demand away from the black market.
We will follow the science, enforce the law, and deliver the clarity patients, providers, and pharmacies deserve.
2013. Obama is asked why his administration is deporting so many people and separating families.
Obama: I'm the President, not the Emperor. I have to enforce the law even if it is tragic and heartbreaking.